GLP-1 use was also associated with fewer psychiatric emergency department visits. The association was observed mainly with ...
The list of illnesses that seem to benefit from treatment with GLP-1 agonists seems to get ever longer, and a study has ...
The estimated 5-year risk for the renal outcome was 2.4 vs 2.1% for people taking GLP-1 receptor agonists or SGLT-2 inhibitors vs those taking DPP-4 inhibitors. HealthDay News — For adults with type 2 ...
Medications commonly used to treat diabetes and induce weight loss may reduce the risk of cancer progressing, new research has suggested. “Our study found that use of GLP-1 drugs, compared to DPP-4 ...